The 15th Annual BIO CEO & Investor Conference
The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.
BIO One-on-One Partnering provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads.
More about One-on-One Partnering events
Subscribe to the BIO Business Link, a biweekly newsletter featuring in-depth industry analysis and critical thinking.
Early bird rates end December 18!
2013 Conference News and Updates
- Fireside Chats Back for 2013, Featuring Biopharma CEOs
- Now Accepting Company Presentation Applications from Qualified Public & Private Companies
- New for 2013, a Company Presentation Track for Select Private Companies
2012 Presenting Company Highlights
- $EXEL Grabs First FDA Nod for Blockbuster Hopeful Against Thyroid
- Acadia Surges on Parkinson's Psychosis Drug Study
- Rib-X Lands $67.5 Million To Advance Antibiotic Drug Research
- Alnylam Gets $22.5M from Genzyme for Asia Rights to Amyloidosis Drug
Biotech Industry News and Analysis
- Social Media, iPhone App Aid Efforts to Crowdsource Disease Surveillance
- Who Are Biotech’s New Go-To Investment Bankers?
- Thoughts on Bio-Pharma Investor Sentiment Going Into 2013
- The Good, the Bad, and the Ugly for Biotech IPOs
